Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, represented the Colorado life sciences ecosystem and advocated for community priorities on Capitol Hill last week during the Biotechnology Innovation Organization (BIO) Council of State Bioscience Associations (CSBA) 2024 Fly-In.
CBSA shared exciting updates about the growth and health of the life sciences ecosystem in Colorado and addressed some of the top concerns and priorities of CBSA members with Colorado’s Congressional delegation.
Thank you to the staffs of Sen. John Hickenlooper, Rep. Diana DeGette, Rep. Joe Neguse, and Rep. Brittany Pettersen for speaking with CBSA about boosting research into new treatments and cures for patients.
The topics CBSA discussed included:
- The Need to Restore Immediate R&D Expensing: Members of CBSA continue to be very concerned about the 2022 change to Section 174…
Click here to view original postClick Here to Publish/Feature Your Company or Product News with Biotech Networks
